ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,884Medicare Part D Prescriptions Filled, Including Refills

Rank: 232 out of 680

$517K Total Retail Price of All Prescriptions

Rank: 276 out of 680

388 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 388 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 8,841 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
SIMVASTATIN 730 678 1 3
AMLODIPINE BESYLATE 579 533 2 1
LEVOTHYROXINE SODIUM 451 406 3 2
LISINOPRIL 328 267 4 5
HYDROCHLOROTHIAZIDE 279 262 5 9
METFORMIN HCL 278 244 6 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 277 244 7 37
ATORVASTATIN CALCIUM 252 228 8 11
METOPROLOL SUCCINATE 203 198 9 13
ATENOLOL 203 179 9 19
SERTRALINE HCL 202 177 11 28
LOSARTAN POTASSIUM 182 170 12 21
PRAVASTATIN SODIUM 182 157 12 10
MELOXICAM 166 157 14 24
LOSARTAN-HYDROCHLOROTHIAZIDE 155 150 15 51
OMEPRAZOLE 153 143 16 7
FUROSEMIDE 137 131 17 6
GABAPENTIN 127 110 18 15
POTASSIUM CHLORIDE 115 112 19 14
NEXIUM 112 90 20 16
CLOPIDOGREL 107 92 21 26
ZOLPIDEM TARTRATE 102 97 22 17
CRESTOR 94 81 23 25
TRAMADOL HCL 90 81 24 18
METOPROLOL TARTRATE 88 72 25 12
PANTOPRAZOLE SODIUM 87 83 26 30
PAROXETINE HCL 84 67 27 76
ISOSORBIDE MONONITRATE ER 84 77 27 59
AMITRIPTYLINE HCL 83 58 R 29 47
PLAVIX 79 71 30 39
FENOFIBRATE 79 56 30 66
GLIPIZIDE ER 76 60 32 108
WARFARIN SODIUM 72 57 33 20
FLUTICASONE PROPIONATE 72 57 33 41
FLUOXETINE HCL 71 71 35 74
AZITHROMYCIN 68 56 36 42
LIPITOR 67 67 37 68
DIGOXIN 62 44 38 58
DIOVAN HCT 62 60 38 55
TRICOR 59 43 40 98
DONEPEZIL HCL 55 42 41 27
NIFEDIPINE ER 55 54 41 75
GLIPIZIDE 54 54 43 63
HYDROCODONE-ACETAMINOPHEN 54 50 S3 43 4
ENALAPRIL MALEATE 51 51 45 65
ALENDRONATE SODIUM 51 51 45 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 18, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.